206
Views
8
CrossRef citations to date
0
Altmetric
Letter

Chronic lymphocytic leukemia associated with immunotactoid glomerulopathy: a case report of successful treatment with high-dose methylprednisolone in combination with rituximab followed by alemtuzumab

, , , , &
Pages 1835-1838 | Received 30 Nov 2011, Accepted 30 Jan 2012, Published online: 13 Mar 2012

References

  • Henriksen KJ, Hong RB, Sobrero MI, . Rare association of chronic lymphocytic leukemia/small lymphocytic lymphoma, ANCAs, and pauci-immune crescentic glomerulonephritis. Am J Kidney Dis 2011;57:170–174.
  • Seney FD Jr, Federgreen WR, Stein H, . A review of nephrotic syndrome associated with chronic lymphocytic leukemia. Arch Intern Med 1986;146:137–141.
  • Butty H, Asfoura J, Cortese F, . Chronic lymphocytic leukemia-associated membranous glomerulopathy: remission with fludarabine. Am J Kidney Dis 1999;33:E8.
  • Da'as N, Polliack A, Cohen Y, . Kidney involvement and renal manifestations in non-Hodgkin's lymphoma and lymphocytic leukemia: a retrospective study in 700 patients. Eur J Haematol 2001;67:158–164.
  • Barbour SJ, Beaulieu MC, Zalunardo NY, . Proliferative glomerulonephritis with monoclonal IgG deposits secondary to chronic lymphocytic leukemia. Report of two cases. Nephrol Dial Transplant 2011;26:2712–2714.
  • Castro JE, Sandoval-Sus JD, Bole J, . Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia. Leukemia 2008;22:2048–2053.
  • Castro JE, James DF, Sandoval-Sus JD, . Rituximab in combination with high-dose methylprednisolone for the treatment of chronic lymphocytic leukemia. Leukemia 2009;23:1779–1789.
  • Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 2004;127:3–11.
  • Mallouk A, Pham PT, Pham PC. Concurrent FSGS and Hodgkin's lymphoma: case report and literature review on the link between nephrotic glomerulopathies and hematological malignancies. Clin Exp Nephrol 2006;10:284–289.
  • Yahata N, Kawanishi Y, Okabe S, . Membranous glomerulonephritis with nephrotic syndrome associated with chronic lymphocytic leukemia. Am J Nephrol 2000;20:402–407.
  • Alzamora MG, Schmidli M, Hess U, . Minimal change glomerulonephritis in chronic lymphocytic leukemia: pathophysiological and therapeutic aspects. Onkologie 2006;29:153–156.
  • Bridoux F, Hugue V, Coldefy O, . Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features. Kidney Int 2002;62:1764–1775.
  • Wierda WG, Cantwell MJ, Woods SJ, . CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia. Blood 2000;96: 2917–2924.
  • Wierda WG, Castro JE, Aguillon R, . A phase I study of immune gene therapy for patients with CLL using a membrane-stable, humanized CD154. Leukemia 2010;24:1893–1900.
  • Hill PA, Firkin F, Dwyer KM, . Membranoproliferative glomerulonephritis in association with chronic lymphocytic leukaemia: a report of three cases. Pathology 2002;34:138–143.
  • King JA, Culpepper RM, Corey GR, . Glomerulopathies with fibrillary deposits. Ultrastruct Pathol 2000;24:15–21.
  • d’Ythurbide G, Coppo P, Adem A, . Chronic lymphocytic leukemia: a hazardous condition before kidney transplantation. Am J Transplant 2008;8:2471–2475.
  • Castro JE, Sandoval-Sus JD, Bole J, . Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia. Leukemia 2008;22:2048–2053.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.